RecruitingNCT06725719

Translocator Protein PET/CT in Various TSPO-Related Disease

Sponsor

Tianjin Medical University

Enrollment

200 participants

Start Date

Nov 1, 2018

Study Type

OBSERVATIONAL

Conditions

Stroke Neuroinflammation Neurodegenerative Diseases

Summary

To evaluate the potential usefulness of 18F-DPA714/FDPA positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various TSPO-related disease patients.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria1

\- (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled TSPO PET/CT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.

Exclusion Criteria1

\- (i) patients with non-malignant lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.

Interested in this trial?

Get notified about updates and connect with the research team.